Empower Clinics (Empower Clinics) Debt-to-EBITDA : -9.22 (As of Sep. 2022)

View and export this data going back to 2010. Start your Free Trial

What is Empower Clinics Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Empower Clinics's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2022 was $0.77 Mil. Empower Clinics's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2022 was $4.09 Mil. Empower Clinics's annualized EBITDA for the quarter that ended in Sep. 2022 was $-0.53 Mil. Empower Clinics's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2022 was -9.22.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Empower Clinics's Debt-to-EBITDA or its related term are showing as below:

EPWCF's Debt-to-EBITDA is not ranked ^*
in the Healthcare Providers & Services industry.
Industry Median: 2.57
* Ranked among companies with meaningful Debt-to-EBITDA only.

Empower Clinics Debt-to-EBITDA Historical Data

The historical data trend for Empower Clinics's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Empower Clinics Debt-to-EBITDA Chart

Empower Clinics Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Debt-to-EBITDA

Get a 7-Day Free Trial

-0.04

-0.53

-0.85

-0.22

-0.15

Empower Clinics Quarterly Data
	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Debt-to-EBITDA	Get a 7-Day Free Trial															-0.45	-0.26	-0.60	0.51	-9.22

Competitive Comparison of Empower Clinics's Debt-to-EBITDA

For the Medical Care Facilities subindustry, Empower Clinics's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Empower Clinics's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Empower Clinics's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Empower Clinics's Debt-to-EBITDA falls into.

Empower Clinics Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Empower Clinics's Debt-to-EBITDA for the fiscal year that ended in Dec. 2021 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(0.894	+	3.704)	/	-31.011
	=	-0.15

Empower Clinics's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2022 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(0.774	+	4.092)	/	-0.528
	=	-9.22

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Sep. 2022) EBITDA data.

Empower Clinics (OTCPK:EPWCF) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Empower Clinics Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Empower Clinics's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Empower Clinics (Empower Clinics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Empower Clinics Inc (OTCPK:EPWCF) » Definitions » Debt-to-EBITDA

Comparable Companies

Traded in Other Exchanges

N/A

Address

1771 Robson Street, Suite 505, Vancouver, BC, CAN, V6G 1C9

Website

https://www.empowerclinics.com

Empower Clinics Inc is an integrated healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care, and medical diagnostics laboratories. The company has a clinical and digital presence across North America. The firm's Health & Wellness and Diagnostics & Technology business units are positioned to positively impact the integrated health of its patients, while simultaneously providing long-term value for its shareholders.

Executives

John Kenneth Campbell	director	905 WEST PENDER ST STE 500, VANCOUVER BC CANADA A1 V6C1L6
Dan Brown	director	4615 232ND STREET, LANGLEY A1 V2Z 2S1
Michael Barry Hart	officer: Pres/Prin Exe Officer/Sec/Trea	3331 BEACH AVE, ROBERTS CREEK A1 V0N 2W2
Garth Johnson	officer: CFO	1407 - 1050 BURRARD ST., VANCOUVER A1 V6Z 2S3
Trans Orient Petroleum Ltd/	10 percent owner	WORLD TRADE CENTRE, SUITE 404-999 CANADA PLACE, VANCOUVER A1 V6C 3E2
Robert Pollock	10 percent owner	94 GARFIELD AVENUE, TORONTO A6 M4T 1G1
Doug Lynes	director	SUITE 350 - 6165 HIGHWAY 17, DELTA A1 V4K 5B8
Alex Guidi	10 percent owner	1055 WEST GEORGIA STREET, SUITE 1500, VANCOUVER A1 V6E 4N7